Which of the following is not true about Barrett’s esophagus?

Explanation

## Correct Answer: D. Mucus secreting foveolar cells are characteristic Barrett's esophagus is characterized by **columnar metaplasia** of the normal squamous epithelium of the esophagus, typically in response to chronic gastroesophageal reflux disease (GERD). The key histological feature is the presence of **specialized intestinal metaplasia** with goblet cells (mucus-secreting cells), not foveolar cells. Foveolar cells are characteristic of gastric mucosa (fundic glands), not Barrett's esophagus. While Barrett's epithelium does contain mucus-secreting cells, these are specifically **goblet cells** (intestinal-type), not the foveolar cells seen in gastric mucosa. The presence of goblet cells is what defines "specialized intestinal metaplasia" and is the hallmark of Barrett's esophagus. Foveolar cells would indicate gastric-type metaplasia, which is a different and less significant finding. This distinction is critical in Indian pathology practice where accurate histological diagnosis determines surveillance protocols and cancer risk stratification. The question tests whether students can differentiate between goblet cells (Barrett's) and foveolar cells (gastric mucosa). ## Why the other options are wrong **A. Alician blue is used in the staining of biopsy specimen** — This is TRUE. Alcian blue (note: question spells it 'Alician') is a histochemical stain used to identify mucin-secreting cells, particularly goblet cells in Barrett's esophagus. It stains acidic mucopolysaccharides blue, confirming the presence of intestinal metaplasia. This is a standard staining technique in Indian pathology labs for Barrett's diagnosis. **B. It is a reversible cell adaption** — This is TRUE. Barrett's esophagus represents **reversible metaplasia** — a cell adaptation where one differentiated cell type is replaced by another in response to chronic irritation (GERD). Early Barrett's can regress with aggressive acid suppression therapy, particularly in Indian patients with newly diagnosed GERD. This reversibility distinguishes it from dysplasia or cancer. **C. It is the intestinal metaplasia of esophagus** — This is TRUE and is the defining characteristic of Barrett's esophagus. The normal squamous epithelium of the esophagus undergoes **specialized intestinal metaplasia** with goblet cells (not foveolar cells) in response to chronic GERD. This intestinal-type columnar epithelium with goblet cells is the pathognomonic finding that defines Barrett's esophagus in all major textbooks. ## High-Yield Facts - **Goblet cells** (not foveolar cells) are the characteristic mucus-secreting cells in Barrett's esophagus - **Alcian blue stain** identifies goblet cells and confirms specialized intestinal metaplasia in Barrett's - Barrett's esophagus is **reversible metaplasia** if GERD is controlled early; long-standing disease carries 0.2–0.5% annual cancer risk - **Intestinal metaplasia with goblet cells** (not gastric-type foveolar cells) defines Barrett's and increases dysplasia/adenocarcinoma risk - Indian GERD prevalence is rising; Barrett's surveillance requires endoscopy every 2–3 years per IAP guidelines if no dysplasia ## Mnemonics **GOBLET not FOVEOLAR** Barrett's = **G**oblet cells (intestinal type); Gastric mucosa = **F**oveolar cells (gastric type). Remember: Barrett's is intestinal metaplasia, so it has intestinal-type goblet cells, not gastric foveolar cells. **ABCD of Barrett's** **A**lcian blue stain, **B**arrett's = intestinal metaplasia, **C**hronic GERD trigger, **D**ysplasia risk. (Note: D is NOT foveolar cells — that's the trap.) ## NBE Trap NBE pairs "mucus-secreting cells" with Barrett's to lure students into selecting foveolar cells (which ARE mucus-secreting but are gastric, not Barrett's). The trap conflates "mucus-secreting" with "foveolar" — students must know that Barrett's has goblet cells, not foveolar cells. ## Clinical Pearl In Indian practice, Barrett's esophagus is increasingly recognized in GERD patients with alarm symptoms (dysphagia, weight loss). Early diagnosis via endoscopy with targeted biopsies and Alcian blue staining can identify goblet cells and guide surveillance intensity — reversibility is possible only if acid suppression is aggressive and early, making histological accuracy critical for patient counseling. _Reference: Robbins & Cotran Pathologic Basis of Disease, Ch. 15 (GI Pathology); Bailey & Love's Short Practice of Surgery, Ch. 23 (Esophagus)_